Celivarone

Generic Name: Celivarone

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₃₄H_₄₇NO_₄

CAS Number: 401925-43-7

Unique Ingredient Identifier: K45001587E

Background: Celivarone is under investigation in clinical trial NCT00233441 (Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 Mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/flutter).

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Dose Ranging Study of Celivarone With Amiodarone as Calibrator for the Prevention of Implantable Cardioverter Defibrillator (ICD) Interventions or Death

Phase 2

Completed

Conditions: Arrhythmia Prophylaxis
Ventricular Arrhythmia

Interventions: Drug: Celivarone
Drug: Amiodarone
Drug: Matching placebo

First Posted Date: 2009-10-12

Last Posted Date: 2016-05-30

Lead Sponsor: Sanofi

Target Recruit Count: 486

Registration Number: NCT00993382

Locations: 🇺🇸
Investigational Site Number 840045, Chicago, Illinois, United States
🇩🇪
Investigational Site Number 276005, Bad Neustadt, Germany
🇦🇺
Investigational Site Number 036003, Woolloongabba, Australia

and more 148 locations

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy